News
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...
FRANKFURT: European shares were unchanged on Friday, as losses in heavyweight healthcare shares were countered by ...
US and European stock markets stalled or trimmed gains on Friday after a bullish week buoyed by US data and upbeat company ...
Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Kraft Heinz, whose Maxwell House and Gevalia would be hit hard by new duties on coffee beans, retained WilmerHale to lobby on tariffs beginning on May 1, according to a disclosure filing.
If you have a pension or investment portfolio there is one fund type that you must hold - and while it will have made you excellent returns, experts now warn its future is far more precarious.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results